建立基于口腔癌低氧相关基因的化疗预测模型
Chuhuan Zhou1,2, Hanqi Jia1, Nan Jiang1,2
1Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Journal of Cancer
|September 9, 2024
概括
这项研究确定了与口腔癌化疗耐药性相关的缺氧基因. 一个机器学习模型预测了治疗反应,突出了ALDOA作为与低氧条件下的耐药性相关的关键基因.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 计算生物学 计算生物学
背景情况:
- 化疗耐药性仍然是口腔癌治疗的一个重大挑战.
- 缺氧越来越被认为是影响治疗疗效的因素.
- 鉴定化疗反应的预测生物标志物对于个性化医学至关重要.
研究的目的:
- 确定与口腔癌中化疗耐药性相关的缺氧相关基因.
- 使用机器学习算法开发化疗反应的预测模型.
- 调查已识别的基因在口腔癌预后和免疫透中的作用.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库来获取口腔癌患者数据 (n=72).
- 采用差异基因表达分析 (Limma) 和单变量分析来识别关键基因.
- 构建和评估机器学习模型 (包括XGBoost) 来预测化疗反应.
- 进行了激光回归来识别核心基因,并分析了预后和免疫透.
主要成果:
- 确定了22个与缺氧相关的差异基因和6个化疗反应基因.
- XGBoost显示了化学疗法反应的最高预测性能.
- ALDOA被确定为一个与化疗耐药性显著相关的核心基因.
- 在缺氧下ALDOA的高表达与较差的治疗结果相关.
结论:
- 使用机器学习成功开发了一种针对口腔癌的强大的化疗反应预测模型.
- 这项研究强调了低氧下高ALDOA表达与口腔癌中化疗耐药性之间的联系.
- 这些发现为口腔癌治疗提供了潜在的治疗标和预测生物标志物.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334